Molecular Imaging: The Bridge from Human Phenome to Personalized Precision Medicine

Overview

Journal Eur J Nucl Med Mol Imaging

Specialties Biophysics
Nuclear Medicine
Radiology

Date 2024 Dec 26

PMID 39724182

Authors

Mei Tian

Yidan Gao

Chenxi Xue

Chentao Jin

Hong Zhang

Affiliations

Soon will be listed here.

Citing Articles

Comparison of Cu-DOTA-PSMA-3Q and Cu-NOTA-PSMA-3Q utilizing NOTA and DOTA as bifunctional chelators in prostate cancer: preclinical assessment and preliminary clinical PET/CT imaging.

Liu H, Zhang X, Zhang J, Pan Y, Wen H, Xu X Eur J Nucl Med Mol Imaging. 2025; .

PMID: 39954062 DOI: 10.1007/s00259-025-07131-3.

References

Venter J, Adams M, Myers E, Li P, Mural R, Sutton G . The sequence of the human genome. Science. 2001; 291(5507):1304-51. DOI: 10.1126/science.1058040. View

Dewanjee M, Ghafouripour A, Kapadvanjwala M, Dewanjee S, Serafini A, Lopez D . Noninvasive imaging of c-myc oncogene messenger RNA with indium-111-antisense probes in a mammary tumor-bearing mouse model. J Nucl Med. 1994; 35(6):1054-63. View

Gambhir S, Barrio J, Wu L, Iyer M, Namavari M, Satyamurthy N . Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. J Nucl Med. 1998; 39(11):2003-11. View

Rogers B, Zinn K, Buchsbaum D . Gene transfer strategies for improving radiolabeled peptide imaging and therapy. Q J Nucl Med. 2000; 44(3):208-23. View

Ellenberg J, Lippincott-Schwartz J, Presley J . Dual-colour imaging with GFP variants. Trends Cell Biol. 1999; 9(2):52-6. DOI: 10.1016/s0962-8924(98)01420-2. View

Ponomarev V, Doubrovin M, Lyddane C, Beresten T, Balatoni J, Bornman W . Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo. Neoplasia. 2002; 3(6):480-8. PMC: 1506564. DOI: 10.1038/sj.neo.7900204. View

Wang Y, Yu Y, Shabahang S, Wang G, Szalay A . Renilla luciferase- Aequorea GFP (Ruc-GFP) fusion protein, a novel dual reporter for real-time imaging of gene expression in cell cultures and in live animals. Mol Genet Genomics. 2002; 268(2):160-8. DOI: 10.1007/s00438-002-0751-9. View

Ponomarev V, Doubrovin M, Serganova I, Vider J, Shavrin A, Beresten T . A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. Eur J Nucl Med Mol Imaging. 2004; 31(5):740-51. DOI: 10.1007/s00259-003-1441-5. View

Wang T, Antonacci-Fulton L, Howe K, Lawson H, Lucas J, Phillippy A . The Human Pangenome Project: a global resource to map genomic diversity. Nature. 2022; 604(7906):437-446. PMC: 9402379. DOI: 10.1038/s41586-022-04601-8. View

10.

Tian M, He X, Jin C, He X, Wu S, Zhou R . Transpathology: molecular imaging-based pathology. Eur J Nucl Med Mol Imaging. 2021; 48(8):2338-2350. PMC: 8241651. DOI: 10.1007/s00259-021-05234-1. View

11.

Fanti S, Goffin K, Hadaschik B, Herrmann K, Maurer T, MacLennan S . Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer. Eur J Nucl Med Mol Imaging. 2020; 48(2):469-476. PMC: 7835167. DOI: 10.1007/s00259-020-04934-4. View

12.

Tian M, Zuo C, Civelek A, Carrio I, Watanabe Y, Kang K . International Nuclear Medicine Consensus on the Clinical Use of Amyloid Positron Emission Tomography in Alzheimer's Disease. Phenomics. 2023; 3(4):375-389. PMC: 10425321. DOI: 10.1007/s43657-022-00068-9. View

13.

Tian M, Civelek A, Carrio I, Watanabe Y, Kang K, Murakami K . International consensus on the use of tau PET imaging agent F-flortaucipir in Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2022; 49(3):895-904. PMC: 8803772. DOI: 10.1007/s00259-021-05673-w. View

14.

Gao P, Liu Y, Wang X, Feng X, Liu H, Liu S . Adhesion molecule-targeted magnetic particle imaging nanoprobe for visualization of inflammation in acute lung injury. Eur J Nucl Med Mol Imaging. 2023; 51(5):1233-1245. DOI: 10.1007/s00259-023-06550-4. View

15.

Tian M, Watanabe Y, Kang K, Murakami K, Chiti A, Carrio I . International consensus on the use of [F]-FDG PET/CT in pediatric patients affected by epilepsy. Eur J Nucl Med Mol Imaging. 2021; 48(12):3827-3834. DOI: 10.1007/s00259-021-05524-8. View

16.

Schillaci O, Urbano N . Personalized medicine: a new option for nuclear medicine and molecular imaging in the third millennium. Eur J Nucl Med Mol Imaging. 2017; 44(4):563-566. DOI: 10.1007/s00259-017-3616-5. View

17.

Kang S, Jeong H, Baek J, Lee S, Han S, Cho H . PiB-PET Imaging-Based Serum Proteome Profiles Predict Mild Cognitive Impairment and Alzheimer's Disease. J Alzheimers Dis. 2016; 53(4):1563-76. DOI: 10.3233/JAD-160025. View

18.

Chung Y, Tsai C, Yu C, Wang W, Yang C, Hong J . Radiation-Induced Metabolic Shifts in the Hepatic Parenchyma: Findings from F-FDG PET Imaging and Tissue NMR Metabolomics in a Mouse Model for Hepatocellular Carcinoma. Molecules. 2021; 26(9). PMC: 8125521. DOI: 10.3390/molecules26092573. View

19.

Pelletier-Galarneau M, Petibon Y, Ma C, Han P, Kim S, Detmer F . In vivo quantitative mapping of human mitochondrial cardiac membrane potential: a feasibility study. Eur J Nucl Med Mol Imaging. 2020; 48(2):414-420. PMC: 7839097. DOI: 10.1007/s00259-020-04878-9. View

20.

Kaczynski J, Sellers S, Seidman M, Syed M, Dennis M, Mcnaught G . F-NaF PET/MRI for Detection of Carotid Atheroma in Acute Neurovascular Syndrome. Radiology. 2022; 305(1):137-148. PMC: 9523682. DOI: 10.1148/radiol.212283. View